Neuropen
Neuropen is an effective aid to peripheral neuropathy foot screening
Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation¹.
Treatment of these complications can be expensive², yet many are avoidable³, making early identification and intervention key to improving patient outcomes and reducing health costs.
Neuropen is the only peripheral neuropathy screening device incorporating pressure and sharpness tests, giving clinicians a simple, compact solution for testing large and small nerve fibres in the foot.
Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments.
Neuropen is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual-purpose, pocket-sized device designed to provide a safe and reliable test.
How Neuropen works
The Neuropen is a reusable device that can deliver:
- A 10g pressure test using Neuropen Monofilaments to assess any reduction in sensation in the tested area.
- A 40g sharpness test using Neurotips single-use neurological examination pins to assess reduced sensation to sharpness or pain in small nerve fibres.
More from our range of neuropathy devices
References
1. Guttormsen K, Chadwick P (2017) Diabetic neuropathy: Beyond the basics. Journal of Diabetes Nursing 21: 17–22.
2. Nice estimates that around £650 million (or £1 in every £150 the NHS spends) is on foot ulcers or amputations each year. Accessed 22 July 2025
3. State of the nation 2016, Diabetes UK
